Despite substantial progress in prevention of perinatal group B streptococcal (GBS) disease since the 1990s, GBS remains the leading cause of early-onset neonatal sepsis in the United States. In 1996, ...
Streptococcus agalactiae (known as Group B Streptococcus, or GBS) is present in the genital tract in around one in five women. Previous research by the team at the University of Cambridge and Rosie ...
We identified 1726 cases of late-onset neonatal GBS disease between January 1990 and December 2005. Seventy-nine percent of isolates were obtained from blood, 19% from cerebrospinal fluid, 2% from ...
In a recent study published in Nature Microbiology, a group of researchers investigated the clinical significance of Streptococcus agalactiae (Group B Streptococcus; GBS) deoxyribonucleic acid (DNA) ...
Infants born to mothers whose placentas are infected with group B Streptococcus (GBS) are at an increased risk of neonatal unit (NNU) admission and sepsis, according to a new study from the University ...
In this study, researchers evaluated the clinical features of group B streptococcal infections (GBS) in women who were pregnant, as well as neonatal outcomes associated with GBS infection. Among women ...
Group B Streptococcus (GBS), a bacterial pathogen that causes sepsis and meningitis in newborn infants, is able to shut down immune cell function in order to promote its own survival, according to ...
Researchers in Norway studied rates of fatalities and long-term neurodevelopmental disorders among 866 infants diagnosed with GBS infection. Children with GBS meningitis died at higher rates than ...
One in 200 newborns is admitted to a neonatal unit with sepsis caused by a bacteria commonly carried by their mothers -- much greater than the previous estimate, say researchers. The team has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback